COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility

Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) raises concerns as to whether it contributes to an increased mortality. The incidence of CAPA varies widely within hospitals and countries, partly because of difficulties in obtaining a reliable diagnosis. We implemented a...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nina Lackner, Claudius Thomé, Dietmar Öfner, Michael Joannidis, Timo Mayerhöfer, Rohit Arora, Eldina Samardzic, Wilfried Posch, Robert Breitkopf, Cornelia Lass-Flörl
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-01-01
Col·lecció:	Journal of Fungi
Matèries:	aspergillosis COVID-19 coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) antifungal susceptibility testing fungal diagnosis
Accés en línia:	https://www.mdpi.com/2309-608X/8/2/93
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!